BridgeMD
New treatment option for Type 1 Diabetes Mellitus (T1DM)
Official title GlycoQuest: An AI-Adaptive CGM-Integrated Serious Game for Pediatric Type 1 Diabetes
ClinicalTrials.gov ID: NCT07726680
What this study is testing
- What it's testing
- Type 1 diabetes diagnosed in childhood requires rapid acquisition of complex self-management skills while children and caregivers are also adapting emotionally and socially to a chronic condition. Standard diabetes education is often delivered early after diagnosis, is information intensive, and is not usually personalized to real-time glucose patterns, emotional state, child developmental stage, or family communication needs.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 6 to 17
You may be able to join if
- Child or adolescent aged 6 to 17 years at enrollment.
- Diagnosis of type 1 diabetes confirmed by a pediatric endocrinologist according to standard clinical criteria.
- Type 1 diabetes diagnosed within the previous 3 months.
- Primary caregiver aged 18 years or older willing to participate as part of a parent-child dyad.
- Current use of continuous glucose monitoring or willingness to initiate CGM as part of standard diabetes care.
You likely can't join if
- Type 1 diabetes diagnosed more than 3 months before enrollment.
- Concurrent participation in another intensive diabetes behavioral intervention trial.
- Significant developmental, intellectual, visual, motor, or psychiatric condition that, in the opinion of the clinical team, would preclude meaningful...
- Acute psychiatric instability or safety concern requiring urgent specialist intervention.
- Planned transfer to a different diabetes care provider within 6 months.
- Absence of internet access that cannot be addressed by study support.
See the full eligibility criteria
- Child or adolescent aged 6 to 17 years at enrollment.
- Diagnosis of type 1 diabetes confirmed by a pediatric endocrinologist according to standard clinical criteria.
- Type 1 diabetes diagnosed within the previous 3 months.
- Primary caregiver aged 18 years or older willing to participate as part of a parent-child dyad.
- Current use of continuous glucose monitoring or willingness to initiate CGM as part of standard diabetes care.
- Household access to a compatible smartphone or tablet, or willingness to use a study-provided device if available.
- Ability of child and caregiver to engage with study procedures and digital intervention content.
- Caregiver able to provide written informed consent.
- Child able to provide age-appropriate assent.
- Type 1 diabetes diagnosed more than 3 months before enrollment.
- Concurrent participation in another intensive diabetes behavioral intervention trial.
- Significant developmental, intellectual, visual, motor, or psychiatric condition that, in the opinion of the clinical team, would preclude meaningful engagement with the digital game interface or study procedures.
- Acute psychiatric instability or safety concern requiring urgent specialist intervention.
- Planned transfer to a different diabetes care provider within 6 months.
- Absence of internet access that cannot be addressed by study support.
The study team makes the final eligibility decision.
Where it's taking place
- Lahore, Punjab Province, Pakistan
Compensation & support
Compensation mentioned.
ClinicalTrials.gov doesn't provide a reliable structured field for payment or travel support - confirm details with the study team.
Questions & answers
Do participants get paid in this trial?
This study's listing includes signals that participants may be compensated or receive a stipend. Amounts vary and are set by the study team - confirm the details with them.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 6 years to 17 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Lahore, Punjab Province, Pakistan. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.